|
| 37449887 | Moving forward together: collaborative landscapes of research in idiopathic inflammatory myopathies and calcinosis. | Rheumatology (Oxford) | 2024 |
| 35929784 | Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies. | Rheumatology (Oxford) | 2023 |
| 38058676 | Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope. | Rheumatol Adv Pract | 2023 |
| 37780048 | Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005-2021). | Front Pediatr | 2023 |
| 35532072 | Panel sequencing links rare, likely damaging gene variants with distinct clinical phenotypes and outcomes in juvenile-onset SLE. | Rheumatology (Oxford) | 2023 |
| 36627168 | Towards development of treat to target (T2T) in childhood-onset systemic lupus erythematosus: PReS-endorsed overarching principles and points-to-consider from an international task force. | Ann Rheum Dis | 2023 |
| 34730824 | An unusual case of enterovirus infection with polymyositis and severe necrotizing retinovasculitis in a 10-year-old boy. | Rheumatology (Oxford) | 2022 |
| 35355064 | British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy. | Rheumatology (Oxford) | 2022 |
| 35513304 | Real world treatment of juvenile-onset systemic lupus erythematosus: Data from the UK JSLE cohort study. | Clin Immunol | 2022 |
| 36384526 | Juvenile Dermatomyositis: what comes next? Long-term outcomes in childhood myositis from a patient perspective. | Pediatr Rheumatol Online J | 2022 |
| 34894234 | Attainment of low disease activity and remission targets reduces the risk of severe flare and new damage in childhood lupus. | Rheumatology (Oxford) | 2022 |
| 35134124 | Prospective epidemiological study of juvenile-onset systemic lupus erythematosus in the UK and Republic of Ireland. | Rheumatology (Oxford) | 2022 |
| 33147624 | Consensus-based recommendations for the management of juvenile systemic sclerosis. | Rheumatology (Oxford) | 2021 |
| 33629109 | 'It is good to have a target in mind': qualitative views of patients and parents informing a treat to target clinical trial in juvenile-onset systemic lupus erythematosus. | Rheumatology (Oxford) | 2021 |
| 33528490 | Comparison of treatments and outcomes of children with juvenile dermatomyositis followed at two European tertiary care referral centers. | Rheumatology (Oxford) | 2021 |
| 33690793 | Limited sensitivity and specificity of the ACR/EULAR-2019 classification criteria for SLE in JSLE?-observations from the UK JSLE Cohort Study. | Rheumatology (Oxford) | 2021 |
| 33555459 | Treatment of Calcinosis in Juvenile Dermatomyositis. | Curr Rheumatol Rep | 2021 |
| 34758253 | 100,000 Genomes Pilot on Rare-Disease Diagnosis in Health Care - Preliminary Report. | N Engl J Med | 2021 |
| 34601989 | Neuropsychiatric involvement in juvenile-onset systemic lupus erythematosus: Data from the UK Juvenile-onset systemic lupus erythematosus cohort study. | Lupus | 2021 |
| 34531304 | Efficacy and safety of belimumab in paediatric and adult patients with systemic lupus erythematosus: an across-study comparison. | RMD Open | 2021 |
| 33146389 | Identification and prediction of novel classes of long-term disease trajectories for patients with juvenile dermatomyositis using growth mixture models. | Rheumatology (Oxford) | 2021 |
| 33191283 | Development and Testing of Reduced Versions of the Manual Muscle Test-8 in Juvenile Dermatomyositis. | J Rheumatol | 2021 |
| 33393715 | The Vasculopathy of Juvenile Dermatomyositis: Endothelial Injury, Hypercoagulability, and Increased Arterial Stiffness. | Arthritis Rheumatol | 2021 |
| 33413005 | Clinical and laboratory phenotypes in juvenile-onset Systemic Lupus Erythematosus across ethnicities in the UK. | Lupus | 2021 |
| 32233733 | Clinical and laboratory characteristics in juvenile-onset systemic lupus erythematosus across age groups. | Lupus | 2020 |
| 32073621 | European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. | Rheumatology (Oxford) | 2020 |
| 32917212 | A case of Myhre syndrome mimicking juvenile scleroderma. | Pediatr Rheumatol Online J | 2020 |
| 30535127 | European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative. | Rheumatology (Oxford) | 2019 |
| 31388666 | The prevention and treatment of glucocorticoid-induced osteopaenia in juvenile rheumatic disease: A randomised double-blind controlled trial. | EClinicalMedicine | 2019 |
| 31199482 | An international survey of developing classification criteria for juvenile dermatomyositis-scleroderma overlap. | Rheumatology (Oxford) | 2019 |
| 30861625 | Galectin-9 and CXCL10 as Biomarkers for Disease Activity in Juvenile Dermatomyositis: A Longitudinal Cohort Study and Multicohort Validation. | Arthritis Rheumatol | 2019 |
| 30826775 | Consensus-based recommendations for the management of juvenile localised scleroderma. | Ann Rheum Dis | 2019 |
| 30879080 | European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. | Rheumatology (Oxford) | 2019 |
| 30871425 | Outcomes following mycophenolate mofetil versus cyclophosphamide induction treatment for proliferative juvenile-onset lupus nephritis. | Lupus | 2019 |
| 30391651 | A Markov Multi-State model of lupus nephritis urine biomarker panel dynamics in children: Predicting changes in disease activity. | Clin Immunol | 2019 |
| 30690571 | Development and validation of a composite disease activity score for measurement of muscle and skin involvement in juvenile dermatomyositis. | Rheumatology (Oxford) | 2019 |
| 30535249 | European consensus-based recommendations for the diagnosis and treatment of rare paediatric vasculitides - the SHARE initiative. | Rheumatology (Oxford) | 2019 |
| 29069424 | Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership. | Rheumatology (Oxford) | 2018 |
| 30124602 | Juvenile dermatomyositis: novel treatment approaches and outcomes. | Curr Opin Rheumatol | 2018 |
| 29901756 | Introduction of a novel magnetic resonance imaging-based scoring system for assessing disease activity in children with juvenile dermatomyositis. | Rheumatology (Oxford) | 2018 |
| 29592918 | Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative. | Ann Rheum Dis | 2018 |
| 29084729 | Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research. | Ann Rheum Dis | 2018 |
| 29245175 | Development and Testing of a Hybrid Measure of Muscle Strength in Juvenile Dermatomyositis for Use in Routine Care. | Arthritis Care Res (Hoboken) | 2018 |
| 29342499 | Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling. | Arthritis Rheumatol | 2018 |
| 27515057 | Consensus-based recommendations for the management of juvenile dermatomyositis. | Ann Rheum Dis | 2017 |
| 28385804 | 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Ann Rheum Dis | 2017 |
| 28361566 | Evaluation of the ACR and SLICC classification criteria in juvenile-onset systemic lupus erythematosus: a longitudinal analysis. | Lupus | 2017 |
| 28382778 | 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. | Arthritis Rheumatol | 2017 |
| 28473426 | European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative. | Ann Rheum Dis | 2017 |
| 28202739 | Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients. | J Rheumatol | 2017 |